Cargando…
A meningococcal B vaccine induces cross-protection against gonorrhea
PURPOSE: Neisseria meningitidis and Neisseria gonorrhoeae share between 80% and 90% of their genetic sequence. Meningococcal serogroup B vaccines based on outer membrane vesicles—such as VA-MENGOC-BC—could cross-protect against gonorrhea. The aim of this study was to analyze the incidence rates of g...
Autor principal: | Azze, Rolando Felipe Ochoa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Vaccine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689502/ https://www.ncbi.nlm.nih.gov/pubmed/31406692 http://dx.doi.org/10.7774/cevr.2019.8.2.110 |
Ejemplares similares
-
Cross-protection induced by VA-MENGOC-BC® vaccine
por: Ochoa-Azze, Rolando Felipe
Publicado: (2018) -
Association of Group B Meningococcal Vaccine Receipt With Reduced Gonorrhea Incidence Among University Students
por: Robison, Steve G., et al.
Publicado: (2023) -
Inmunoepidemiología y estratégias de vacunación /
por: Ochoa Azze, Rolando Felipe
Publicado: (2008) -
1145. Meningococcal B Immunization for Adolescents in the Presence of Added Gonorrhea Protection: A Public Health Impact Modelling Study in the United States
por: Kocaata, Zeki, et al.
Publicado: (2023) -
Herd Protection against Meningococcal Disease through Vaccination
por: Clark, Stephen A., et al.
Publicado: (2020)